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For recombinant protein production, the use of biological expression systems is one of the most 
important branches of genetic engineering. Bacterial, fungal, mammalian, plant and insect cells 
can be used as expression systems. Among the more popular systems are yeast, such as 
Saccharomyces cerevisiae and Pichia pastoris. These two systems in molecular biology 
represent one of the most popular tools for the production of recombinant proteins. Proper 
protein folding in the endoplasmic reticulum and secretion of proteins using Kex2 as a signal 
peptidase represents one of the main advantages of this expression system. 
As part of the master's thesis, we optimized the expression of several human CYP450 paralogs 
in the methylotrophic yeast Pichia pastoris. During the cultivation of yeasts, the degree of 
aeration, pH of the growth medium and mixing speed were modified. Also, yeast growth and 
enzyme activity following fermentation in bioreactors and shake flasks were compared. The 
catalytic activity of CYP450 was evaluated by incubation of the model drugs testosterone and 
diclofenac in recombinant yeast cultures, extraction of metabolites and their analysis by HPLC.  
Addition of casamino acids to growth media typically has a positive effect on cell growth (the 
richer the medium, the higher the biomass achieved). After biotransformation of testosterone 
or diclofenac and analysis of corresponding metabolites by HPLC, we discovered that the 
addition of casamino acids had no effect on enzyme activity. In the next experiment, we 
monitored the yeast growth curve (i.e., cell concentration and cell mass over time) and there 
was no significant difference between the two growth curves, indicating that the growth of yeast 
cells in our experiments faithfully mirrored the one repored previously under similar conditions. 
After comparing yeast growth in three bioreactors under different conditions (difference in pH, 
aeration and stirring), it can be concluded that the best conditions for growth are at pH 5.0, 
stirring at 1000 rpm and at 30% dO2. 
A comparison between cultivation in bioreactors and shake flasks shows, that the highest 
enzyme activity was detected upon cultivation in bioreactor units. The whole cell enzyme 
activity was 4-fold less than that in bioreactors when the yeast were grown in shake flasks. The 
reason for this is that in bioreactor units one can control conditions and adjust them according 
to the needs of the cultivated organism, which cannot be achieved by growing them in shake 
flasks. 
 
Key words: Pichia pastoris, CYP 450, bioreactor, shake flasks, biotransformation, HPLC, 





Proizvodnja rekombinantnih proteinov z uporabo bioloških ekspresijskih sistemov predstavlja 
eno izmed najpomembnejših vej genskega inženirstva. Dandanes za njihovo proizvodnjo 
uporabljamo različne ekspresijske sisteme, kot so bakterije, kvasovke, sesalske, rastlinske in 
insektne celice. Med najbolj pogosto uporabljene ekspresijske sisteme sodijo kvasovke, kot sta 
Saccharomyces cerevisiae in Pichia pastoris. Ekspresijski sistem P. pastoris je eden izmed 
najbolj priljubljenih in standardnih orodij za proizvodnjo rekombinantnih proteinov v 
molekularni biologiji. Prednost proizvodnje proteinov s P. pastoris je ustrezno zvijanje (v 
endoplazemskem retikulumu) in sekrecija (s pomočjo signalne peptidaze Kex2) v celično 
okolje. Poleg tega je v ekspresijskem sistemu P. pastoris zaradi omejene proizvodnje endogenih 
sekretornih proteinov čiščenje rekombinantnih proteinov enostavno. Čeprav so ekspresijski 
sistemi P. pastoris enostavni za uporabo zaradi natančno določenih procesnih protokolov, je 
potrebna določena stopnja optimizacije postopkov, da dosežemo največjo proizvodnjo 
proteinov. 
V okviru magistrskega dela smo optimizirali izražanje več človeških paralogov CYP450 v 
metilotrofni kvasovki Pichia pastoris. Med gojenjem kvasovk smo spreminjali stopnjo aeracije, 
pH gojišča in hitrost mešanja. Prav tako smo primerjali tudi rast celic med gojenjem v 
bioreaktorjih in erlenmajericah ter aktivnost encimov v suspenziji celic. Katalitično aktivnost 
CYP450 smo ovrednotili z inkubacijo modelnih učinkovin testosterona in diklofenaka v 
kulturah rekombinantnih kvasovk, ekstrakcijo metabolitov in njihovo analizo s HPLC. 
Na začetku laboratorijskega dela smo P. pastoris z izraženimi različnimi paralogi CYP450 
gojili v erlenmajricah na stresalnikih. Namen prvega poskusa je bil določiti vpliv dodatka 
kazamino kislin na rast celic in izražanje encima. Pogoji gojenja so bili: indukcija z 1 % MeOH, 
stresanje s 120 vrt./min pri 28 °C, pri čemer smo celice z metanolom in kazamino kislinami 
inducirali dvakrat na dan (dopoldne in popoldne). Kazamino kisline namreč predstavljajo vir 
dušika, saj kvasovke rastejo bolje v bogatejšem gojišču (večja biomasa, krajši genereacijski 
čas). Drugi poskus je bil podoben prvemu, razlika je bila ta, da smo uporabili druge paraloge 
CYP450, ter da smo za indukcijo celic uporabili le metanol (brez dodatka kazamino kislin; torej 
manj bogato gojišče). Procesa smo zaključili po petih dneh in izvedli biotransformacijo 
testosterona (uporaba pri prvem poskusu) in diklofenaka (uporaba pri obeh poskusih), 





Iz rezultatov poskusov 1 in 2 smo prišli do sklepa, da ima najvišjo aktivnost CYP3A4, zato smo 
želeli njegovo izražanje preveriti še na večji skali, in sicer po fermentaciji v bioreaktorjih. Pri 
prvem poskusu z bioreaktorji smo CYP3A4 v P. pastoris izražali pri različnih pogojih (različen 
pH, koncentracija kisika in hitrost mešanja). Najprej nas je pri tem poskusu zanimalo, kakšna 
je rastna krivulja in ali je ta primerljiva z referenčno (iz literature). Rastno krivuljo smo dobili 
tako, da smo vsak dan (dopoldne in popoldne) jemali vzorce in koncentracijo celic ocenili 
turbidimetrično pri valovni dolžini 600 nm. Poleg jemanja vzorcev za določevanje 
koncentracije celic smo vsak dan odvzeli vzorce kulture iz bioreaktorjev in določili maso celic 
v mililitru kulture. Po koncu poskusa smo kvasovke poželi s centrifugiranjem in izvedli 
biotransformacijo testosterona in diklofenaka. Metabolite smo analizirali z uporabo HPLC. 
Ocenili smo, kateri pogoji za izražanje CYP450 so najoptimalnejši in smo tako poskus 2 
zasnovali na teh pogojih. Poskus 2, ki smo ga izvajali v bioreaktorjih, je bil identičen poskusu 
1, razlika je bila le v pogojih gojenja celic. Iz dobljenih rezultatov (iz poskusov fermentacije v 
erlenmajericah na stresalnikih in bioreaktorjih) smo lahko izvedli primerjavo, kateri pristop je 
za gojenje P. pastoris in izražanje CYP450 najustreznejši.  
V literaturi smo zasledili, da ima dodatek kazamino kislin v gojišče pozitiven vpliv na rast celic. 
Iz rezultatov našega poskusa pa je razvidno, da kazamino kisline niso imele vpliva na rast celic. 
Najvišjo optično gostoto celic smo izmerili pri kvasovkah, ki so izražale CYP450 3A4, 
najmanjšo pa pri sevu BSYBGII (P. pastoris brez vstavljenega gena za CYP). To je bilo 
nepričakovano, saj kvasovkam (divji sev) ni potrebno vlagati energije v biosintezo 
rekombinantnega proteina, torej energijo vlagajo le v razmnoževanje. Pričakovali smo, da 
kvasovke, če jih gojimo v bolj bogatem gojišču (v našem primeru z dodatkom kazamino kislin), 
dosežejo večjo biomaso (se bolj namnožijo) in posledično izdelajo več encima. 
Biotransformacijo diklofenaka smo izvedli s kvasovkami, ki so izražale CYP450 2D6, saj je ta 
encim selektiven za diklofenak in ne katalizira hidroksilacije testosterona. Ker smo pri prvem 
poskusu ugotovili, da kazamino kisline ne vplivajo na rast kvasovk, jih v nadaljnjih poskusih 
nismo več dodajali. 
Rezultati primerjave sevov, ki sta izražala CYP1A1 in CYP2C9, v poskusu II so nam pokazali, 
da je aktivnost encima (sodeč po biokonverziji diklofenaka) CYP2C9 višja. Koncentracija celic 
pa je pri celicah z vstavljenim CYP višja od tiste pri sevu divjega tipa. 
V naslednjem poskusu smo primerjali lastno rastno krivuljo kvasovk s tisto iz literature. Iz 
dobljenega grafa je razvidno, da so na začetku naše celice vstopile v fazo prilagajanja 




Poleg koncentracije celic smo spremljali tudi prirast mase celic na volumen kulture. Tudi ta 
graf je podoben tistemu iz literature.  
Primerjava seva, ki je izražal CYP3A4, v treh bioreaktorjih pri različnih pogojih (primerjali 
smo vpliv hitrosti mešanja, pH in dovedene koncentracije kisika) kaže, da je rast kvasovk in 
posledično aktivnost encima, sodeč po biokonverziji testosterona, najvišja pri  pH 5.0, mešanju 
s 1000 vrt./min in pri 30% dO2. Po primerjavi rezultatov nadaljnjega gojenja kvasovk v dveh 
bioreaktorjih vidimo, da je edina razlika med njima vrednost pH. To nam pove, da ima pH 
pomemben vpliv na rast celic ter, da je nižji pH optimalnejši za rast kvasovk. Glede na dobljene 
rezultate lahko zaključimo, da so najboljši pogoji za rast pri pH 5.0, mešanju s 1000 vrt./min in 
pri 5% dO2.  
Primerjava gojenja v bioreaktorjih in v erlenmajericah na stresalnikih nam pokaže, da smo 
najvišjo aktivnost encima zaznali pri gojenju v bioreaktorskih enotah. Aktivnost encima je bila 
pri gojenju v erlenmajericah štirikrat manjša od tiste v bioreaktorjih. Razlog za to je v tem, da 
imamo v bioreaktorskih enotah nadzorovane pogoje, ki jih lahko spreminjamo in prilagajamo 
glede na potrebe gojenega organizma, kar pa ni mogoče doseči z gojenjem v erlenmajericah.  
 
Ključne besede: Pichia pastoris, CYP 450, bioreaktorske enote, erlenmajerice, 
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 CYP 450 
The discovery of cytochromes P450 dates back to 1955, when a group of hem-thiolate proteins 
were discovered (in rat liver microsomes) whose main function is metabolism of exogenous 
and endogenous compounds. They are located in all cells throughout the body (primarily found 
in liver cells) and contain an active heme iron center that is bound to a cysteine thiolate ligand. 
Different isoforms of CYP450 enzymes are responsible for the metabolism of xenobiotics in 
phase I metabolism and play an important role in the response and toxicity of many drugs. From 
a medical point of view, they are interesting because of their role in activation or deactivation 
of therapeutic agents, convertion of compounds into highly reactive molecules that can cause 
cell damage, and due to their involvement in production of steroid hormones and fatty acid 
metabolism (1, 2). 
The excretion of molecules from the body can be increased by augmenting their solubility in 
water, which is achieved by increasing the polarity. Polarity is increased due to phase I 
monooxidases, as they are able to carry out dealkylation, hydroxylation, dehalogenation and 
oxidation reactions on various lipophilic compounds of exogenous or endogenous origin, often 
followed by conjugation reactions (Figure 1; 3). 
Due to the ability to catalyze the transfer of one molecular oxygen atom to the substrate and 
the reduction of another to water, P450 enzymes are classified as monooxygenases (5). 
  
 Figure 1: The role of CYP450 enzymes in biotransformation 




 CYP450 spectral properties 
CYP450 are characterized by a specific absorption spectrum, which is the reason why they were 
automatically named as P450, despite the fact that their catalytic function was not yet known. 
The letter P in the name refers to the pigment, and 450 represents the wavelength, as the P450 
complex has an absorption peak at 450 nm (5). 
 CYP450 nomenclature 
The Arabic numeral in the name indicates the family, the subfamily is represented by capital 
letters, and finally followed by the Arabic numeral, which indicates a specific enzyme. 
Example: CYP2C9 is a member of the CYP2 family which belongs to the CYP2C subfamily 
and number 4 means allele (Figure 2) (3).  
 Use of CYP450 for biotransformation of testosterone and diclofenac  
The biotransformation method is used to transform organic compounds from one form to 
another with an aim of reducing toxicity of the chemical compounds and to convert chemical 
compounds using enzymatic biocatalysts. The advantages of microbiological biotransformation 
are high stereoselectivity, high activity, mild reaction conditions and finally, it is 
environmentally friendly. The reaction proceeds with the introduction of a hydroxyl group into 
the steroid molecule (Figures 3 and 4) and because of that this is still the most effective method 
for the preparation of certain derivatives with therapeutic use and commercial value (6).  
 Figure 2: The nomenclature of CYP450 enzymes (4) 
 Figure 3: Metabolism of testosterone (7). After biotransformation, 
a metabolite was formed in which a double bond was formed 






 Figure 4: Testosterone conversion (7). 
Cytochrome P450 3A4 catalyse the conversion of testosterone (1) to 6β-hydroxytestosterone 
(2) (Figures 3 and 4). Redox enzymes can oxidise (1) to 4-androstene-3,17-dione (3, 7). P450 
3A4 hydroxylates testosterone (1) in positions 6β, 2β, 1β, and 15β. As an indicator of 
testosterone bioconversion overall efficiency, 6β-hydroxystestosterone (2) is commonly used. 
Oxidation (1) was also observed at positions 2α, 6α, 7α, 11β, 16α (3, 7). 
Diclofenac (DCF) is a biologically active compound and is metabolised by cytochrome P450 
3A4 and 2C8 isoforms (8). Biotransformation of diclofenac results in conjugation of side chain 
carboxyl group or single or multiple hydroxylation (Figure 5), resulting in multiple phenolic 
metabolites that are ultimately mostly converted to glucuronide conjugates (9). DCF 
metabolism consists of: phase I: 4′-hydroxydiclofenac and minor 5′-hydroxydiclofenac, and 2) 
phase II: diclofenac glucuronide and hydroxydiclofenac glucuronides. Phase I metabolits are 
4-hydroxy and 5-hydroxy and phase II metabolits are acylglucuronides of DCF, hydroxy-DCF, 
and DCF-sulfate (10). 




 CYP3A4, CYP2D6, CYP2C9, and CYP1A1 group 
Cytochromes CYP3A4, CYP2D6, CYP2C9, and CYP1A1 are responsible for approximately 
79% of drugs’ oxidation and the main reasons for mentoning this enzymes in master’s thesis 
are explained below: 
1.1.4.1 CYP2C9 
In terms of the number of substrates, it is one of the most important CYP enzymes. It contributes 
to the metabolism of approximately 15% of all drugs metabolised by CYP enzymes (12). 
1.1.4.2 CYP2D6 
It is expressed mainly in the liver (around 3% of all the CYP450 enzymes) and participates in 
metabolism of approximatelly 20% of drugs. Typical substrates for CYP2D6 are 
antidepressants, antiarrhythmics, beta blockers, and opioid analgesics (10). 
1.1.4.3 CYP3A4  
CYP3A4 is the most important enzyme because of the ability of metabolising 50% of commonly 
described drugs. The large interindividual variability in activity results in the exceptional 
susceptibility to inhibition and induction (3). 
1.1.4.4 CYP1A1 
CYP1A1 is of interest mainly because of its ability to activate compounds with carcinogenic 
properties (13). CYP1A1 alleles are involved in various types of cancer (lung, stomach, skin) 
(14). 
 PICHIA PASTORIS 
Pichia pastoris is a methylotrophic yeast that exists in a vegetative haploid state and belongs 
to the class of Ascomycetes. It reproduces by multilateral flowering (vegetative reproduction), 
in which mating and the formation of diploid cells are stimulated by limiting the concentration 
of nitrogen. First, Pichia pastoris is considered homotal, as mating of cells of the same strain 
is possible. Second, mating can occur between haploid cells of the opposite type. This can be 
explained by the fact that if diploid cells are maintained in normal vegetative growth medium, 
they remain diploid, but if they are moved to a nitrogen-restricted medium, they are subject to 




The use of this expression system is preferred due to its great similarity to eukaryotic systems 
(CHO), in terms of price (cheap), fast expression time, and cotranslational and posttranslational 
treatment (O- and N-linked glycosylation and disulfide bond formation) (16). 
Like other expression systems, this eukaryotic system has some disadvantages, for example, 
protein production depends on methanol consumption. The tolerable methanol concentration 
for organisms is up to 5%, and concentration above 5% can be very toxic and can affect cell 
viability and may even stop the production process (14). 
Comparison of P. pastoris to prokaryotic host Escherichia coli and mammalian cell line CHO 
(Chinese hamster ovary cells) is summarized in Table I. 
Table 1 Comparison of E. coli, P. pastoris and CHO cells as expression host systems (16). 
  
Characteristics Escherichia coli  Pichia pastoris  CHO cell 
Doubling time 30 min 60–120 min 24 hr 
Cost of growth 
medium 
Low Low High 
Complexity of growth 
medium 
Minimum Minimum Complex 
Expression level High Low to high Low to moderate 
Extracellular 
expression 
Secretion to periplasm 
Secretion to 
medium 




Refolding may be 
required 
Proper folding 
N‐linked glycosylation None High mannose Complex 
O‐linked glycosylation No Yes Yes 
Phosphorylation & 
acetylation 
No Yes Yes 






 P. pastoris promoter systems 
1.2.1.1 Alcohol oxidase 1 (AOX1) & alcohol oxidase 2 (AOX2) 
Production of heterologous proteins is mainly based on strong inducible and tightly regulated 
promoter of methanol utilization AOX1 and AOX2 genes. The alcohol oxidase which is encoded 
by these two genes is responsible for the catalysis of methanol to formaldehyde (17). Gene 
transcription occurs in the presence of methanol, resulting in the production of large amounts 
of the enzyme AOX. The AOX1 gene produces a larger amount of the AOX enzyme compared 
to AOX2. By eliminating both genes, the strains cannot grow on methanol (methanol using 
minus (Mut−)). However, by knocking out the AOX2 gene will not decelerate growth on 
methanol, and growth rates are comparable to methanol using the plus (Mut +) phenotype (wild 
type) (14). 
Several new AOX1 promoter (PAOX1) libraries have been developed in recent years using 
deletion and insertion methods (18).  
1.2.1.2 GAP promoter 
The glyceraldehyde-3-phosphate dehydrogenase (GAP) promoter is responsible for the strong 
expression of heterologous proteins. This is comparable to the expression of the methanol-
induced alcohol oxidase promoter (AOX1) in Pichia pastoris (19). Simplified cell cultivation 
(there is no need for methanol as a carbon source) is an advantage of using the GAP promoter 
(PGAP), and the advantage of using PAOX1 is to allow the expression of heterologous proteins 
that can be toxic to the host (20). GAP gene is constitutively expressed for glycolysis and 
gluconeogenesis. The strength of PGAP gene expression depends on the carbon source used for 
cell growth. PGAP represents a very attractive alternative to the PAOX1 system. Experiments with 
cells grown on glucose and under the control of PGAP have shown that production is significantly 






Upstream processes include selection of a microbial strain in order to synthesize a particular 
product with the desired commercial value. The goal is to improve the ability of the strain to 
synthesize economic quantities of the product. This process is called fermentation and is usually 
carried out in large tanks called fermenters or bioreactors. They consist of mechanical parts that 
provide appropriate conditions (aeration, cooling, agitation, etc.) and of monitors and regulating 
devices that allow control over microbial growth and synthesis of the selected product by 
providing optimal conditions (21). 
 Bioreactor 
With usage of bioreactors, we ensure an optimal external environment for biological reaction 
systems and thus to achieve optimal efficiency of the bioprocess (22). The advantage of using 
is that we can achieve controlled conditions (gaseous exchange, light intensity, agitation rate, 
temperature, pH changes, etc.), which can generate high multiplication and growth rates and 
biomass accumulation. Disadvantages of using bioreactors, however, are frequent 
contamination, lack of appropriate protocols and production procedures, shear stress, foaming, 
and accumulation of inhibiting metabolites (23). The appropriate type of bioreactor is selected 
according to the understanding of the biological system and its requirements on its physical and 
chemical environment (22). 
Important parameters in bioreactors are: 
- Overpressure: mantaining the overpressure (0.2-0.5 bar) in the upper space to 
ensure the protection against the contamination (24). 
- Temperature: an important parameter of fermentation, as the temperature 
deviation can greatly reduce the growth and productivity of biosynthesis. The 
accuracy must be at least ± 0.5 ° C (24). 
- pH: pH adequacy is usually controlled by "set values" and real pH values. The 
pH is determined with sterilizable electrodes. Peristaltic pumps are used to 
control pH value, which measures the acid and base accordingly (24). 
- Mixing: Mixing in bioreactors is done mechanically with impellers. They are 
located in the center of the bioreactor vessel. Impellers are roughly divided into 
two groups: turbine and paddle. The appropriate impeller is selected according 
to the dimension and volume of the bioreactor, according to the density and 




Bioreactor operation mode is classified as either (26): 
 Batch process; 
 Fed-batch process; or 
 Continuous process. 
1.3.1.1 Batch process 
The batch process represents a closed process which takes place in single-charge bioreactors. 
Bioreactor is filled with fresh medium, heated to desired temperature and than cells are 
inoculated. The process ends when the medium is consumed and cell growth stops. Mass, 
composition and operating conditions can change during the process, but volume of the medium 
stays the same from the begining till the end. Disadvantage of this kind of process is non-
stationarity of the conditions (changeable environment during the bioprocess), which may lead 
to low cell concentration, poor viability, rapid media utilization and low productivity. An 
advantage is short duration of a process and that is why possibility of contamination is lower 
(27). 
Due to their easy set-up and operations, shake flasks are most commonly used as laboratory-
scale cultivation vessels for the production of recombinant proteins (28). Shake flasks are 
mostly used for screening and process optimization on a small scale (29). Their dissadvantage 
is low aeration capacity and because of batch mode cultivation, they cannot provide suitable 
environment for recombinant protein expression (28). 
1.3.1.2 Fed-batch process 
An improved version of the batch process is fed-batch process and is one of the most common 
mode of operation in the bioprocess industry. This type of process starts with inoculation of 
selected microorganisms and cultivation in a batch regime for a certain amount of time, 
followed by the addition of nutrients for feeding purposes. By determination of the limiting 
substrate in the broth, feeding process can begin, but its time profile must be designed so that 
the substrate remains in excess. Because of addition of fresh nutrients in the exponential growth 
phase, extensive biomass accumulation normally occurs. Therefore, when desired product is 
correlated with microbial growth and for achieving high biomass density or high product yield, 




1.3.1.3 Continuous process 
In this type of process, in the exponential phase of microbial growth fresh medium is added 
into the batch system. Thus, a balanced growth with little fluctuation of the nutrients, 
metabolites, cell numbers or biomass is achieved (25). Primarly it is used to prolong the 
production phase of a culture during its growth in a steady-state, to achieve higher biomass 





This master’s thesis will focus on expression of several human CYP450 paralogs (CYP3A4, 
CYP2D6, CYP2C9, CYP1A1) in the methylotrophic yeast Pichia pastoris. During yeast 
cultivation two vessel types (shake flasks and stirred biorecectors) will be utilized, and the 
aeration rate, pH of culture medium and stirring/shaking speed will be optimised. The catalytic 
activity of CYP450 will be evaluated by biotransformation of model substances testosterone 
and diclofenac. Cognate metabolites will be extracted and analysed by HPLC.  
The main purpose of the master's thesis will be to optimize the cultivation of Pichia pastoris 
(expressing the selected human CYP enzymes) in the bioreactor units, to ensure highest 
recombinant enzyme activity. 
The experiment will be devided in 6 parts (also see Experimental schemes I and II): 
I. Ultra yield flask (UYF) experiment I: Cultivation of different strains of P. pastoris 
(expressing CYP3A4_A9, CYP2D6_D8, or CYP2C9 enzymes) and BSYBG11 (wild 
type P. pastoris; it does not express human CYP450) in buffered minimal dextrose 
medium with and without addition of Casamino acids. Bioconversion of 
testosterone and diclofenac will be assessed using HPLC. 
II. Ultra yield flask experiment II: Cultivation of different P. pastoris strains 
(expressing CYP1A1 or CYP2C9 enzymes) and BSYBG11 buffered minimal 
dextrose medium. Bioconversion of diclofenac will be assessed using HPLC. 
III. Cell growth comparison of different strains of P. pastoris (expressing CYP2D6 or 
CYP1A1) and BSYBGII  in UYF. 
IV. Bioreactor experiments: CYP3A4 strain. Testing of different settings [pH, oxygen 
supply, T, stirring rate] in two separate bioreactor experiments. 
V. Measurement of enzymatic activity under different conditions (testosterone 
bioconversion) using HPLC (bioreactor experiments). 






 MATERIALS AND METHODS 
 Materials and equipment 
 Equipment 
EQUIPMENT COMPANY 
LAMINAR FLOW CABINET Bio Consult 
AUTOCLAVE SHP Steriltechnik AG 
AUTOMATIC PIPETS  Eppendorf 
FERMENTORS Sartorius 
CENTRIFUGE Eppendorf  
CENTRIFUGE TUBES (1.5, 2, 15 AND 50 
ML) Greiner Bio-One 
DIGESTORY Prutscher Laboratory Systems 
0.45 µM FILTERS Thermo Fisher Scientific 
REFRIGERATOR (4 °C) Siemens 
HPLC 1200 series, Agilent technologies, Santa Clara, CA 
SYRINGES Braun 
INCUBATOR BINDER GmbH 
SHAKER INCUBATOR (THERMOMIX) Eppendorf  
ICE MACHINE Manitowoc 
MAGNETIC MIXER Heidolph Instruments 
MICROTITER PLATES P96 GBO - Greiner Bio-One 
MICROWAVE Silva 
PIPETTE TIPS (10 µL, 200 µL, 1000  µL) GBO - Greiner Bio-One 
PARAFILM Sigma-Aldrich 
pH meter Accumet 




SINGLE BEAM UV VIS 
SPECTROPHOTOMETER Eppendorf 
10 ML, 25 ML AND 50 ML SEROLOGICAL 
PIPETTES GBO - Greiner Bio-One 
STERILE PETRI DISHES GBO - Greiner Bio-One 
STOPWATCH TFA Dostmann 








Acetonitrile VWR Chemicals BDH 
Agar Carl Roth 
Ammonia Carl Roth 
Bacto™ peptone Becton Dickinson 
Bacto™ yeast extract Becton Dickinson 
Biotin Carl Roth 
Casamino acids Becton Dickinson 
CaSO4·2H2O   Carl Roth 
CoCl2·6H2O Carl Roth 
Glucose Monohydrate Carl Roth 
Glycerol Carl Roth  
H3BO3 Carl Roth  
H3PO4 Carl Roth  
H2SO4 Carl Roth  
KH2PO4 Carl Roth  
K2HPO4 Carl Roth  
KOH Carl Roth  
K2SO4 CHEMSOLUTE®  
Methanol Carl Roth  
MgSO4·7H2O Carl Roth  
MnSO4·H2O Carl Roth  
NaCl Carl Roth  
Sucrose Carl Roth 












 P. pastoris strains 
Table 2 P. pastoris strains used in experiments 
A563_pPpT4-CYP2C9-PDF/CAT-CPR-      
Integ D8  
A563: number of glycerol stock                                                       
pPpT4: plasmid name                                                                                 
PDF/CAT: very strong promotor, found in P. 
pastoris, controls expression of CPR                                                                        
CPR: cytochrome P450 reductase, 




CSC242: number of glycerol stock                                                       
pBSYBiE1: plasmid name                                                                                
PDC: catalase promotor, inducible with 
methanol, very strong                                                                                
CPR: cytochrome P450 reductase, 
regenerates cytochrome P450                                                          
K9: strain 
A570_#6466 IMBT culture 
collection_pPpB1_CYP2D6-                   
spez-Mut1_CPR 
A570_#6466 : number of glycerol stock                                                       
pPpB1: plasmid name                                                                                
PDF: promotor found in P. pastoris, very 
strong promotor 
spez-Mut 1: specialized mutation on gene 1                                                                               
CPR: cytochrome P450 reductase, 
regenerates cytochrome P450              






 Experimental schemes 




Scheme II: Sheme of Bioreactor experiments 
  
P. pastoris strain cultivated on Petri dish (3.3.3.1) 
Pre-culture I (3.3.3.1) 
Pre-culture II (3.3.3.1) 
Batch phase (3.3.3.2) 
Fed batch phase (3.3.3.3) 
Harvest (3.3.4.3) 
Bioconversion (3.3.4.4) 





 Batch fermentation. Ultra yield flask experiment 
Frozen yeast strain stocks (stored at – 80 °C) were streaked on an YPD- zeomycin agar plates 
and incubated at 28 °C overnight. Overnight grown colonies were inoculated into 450 mL 
BMD1 in 2.5 L ultra yield flasks (Fig. 6) and moved to shaker incubator to 28 °C and 120 rpm. 
The entire cultivation process is shown in Table 3. 
Table 3 Protocol of protein expression in P. pastoris using methanol inducible promoters 
Recommended 
schedule 
Timepoint [h]     
Fri afternoon 0 - 
Starting cell culture in 450 ml BMD in 2.5 L 
UYF 
Mon morning ~60  1st induction 50 ml 10 % BMM10 in 450 ml culture  
Mon evening ~68 2nd induction 
5 ml 100 % methanol (final conc. 1%) in 
500 ml culture 
Tue morning ~84 3rd induction 
5 ml 100 % methanol (final conc. 1%) in 
500 ml culture 
Tue evening ~92 4th induction 
5 ml 100 % methanol (final conc. 1%) in 
500 ml culture 
Wen morning ~108 - Harvest  
 Figure 6: Cultivation of P. pastoris in Ultra yield 




 Bioreactor fermentation 
All the metal parts of bioreactor vessel (Fig. 7) are made of stainless steel. The relation between 
the height H and diameter D of bioreactor is within 1.5-2.5. The reactor filling is about 70%. 
Total volume of bioreactor is 7.5 L and working volume is 5 L (32).  
The bioreactor's upper part has: 
- ports for electrodes (pH, pO2, T, p);        
- ports for the supply of feeding medium, 
- pipes for sampling; 
- ports for the connection of the outlet air condenser and filter; 
- drive sealing; 
- air sparger mounting (32). 
The bioreactor's lower part has: 
- discharge valve; 
- sampling device; 
- sparger; 
- mixer's lower drive; 
- heaters (32). 
 





Single colony from an agar plate was transferred to 50 mL BMGY in 250 mL ultra yield flask 
and moved to shaker for incubation at 130 rpm, 28 °C and ~50% humidity (pre-culture I). After 
72 h, the pre-culture II was started by transferring the appropriate volume of pre-culture I to 
100 mL BMGY in 500 mL baffled flask to reach OD600 of 3 (Eq. 1). After four hours, the pre-
culture II was transffered to 7.5 L (5 L working volume) bioreactors (Sartorius BIOSTAT® 
Cplus). Bioreactors were inoculated to an OD600 of ~1.0. 
Equation 1 Volume of pre-culture I to prepare pre-culture II 
 𝑉(𝑖𝑛𝑜𝑐𝑢𝑙𝑢𝑚)[𝑚𝑙] =
𝑐 (𝑡𝑎𝑟𝑔𝑒𝑡 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛)[𝑂𝐷600]𝑥 𝑉 (𝑓𝑖𝑛𝑎𝑙 𝑣𝑜𝑙𝑢𝑚𝑒)[𝑚𝑙]
𝑐 (𝑖𝑛𝑜𝑐𝑢𝑙𝑢𝑚 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛) [𝑂𝐷600]
 
3.3.2.2 Batch phase 
Batch and fed batch cultivations were carried out in a 7.5 L (5 L working volume) bioreactor 
filled with BSM media. Glycerol batch stage is collectively referred to as the biomass 
production phase. We performed two experiments in a row with 
CSC242_pBSYBiE1_CYP3A4_PDFv20_PDC_CPR A9 strain at different conditions. The first 
experiment was carried out at 28 °C, pH 5.0 (two bioreactors), pH 6.0 (one bioreactor) and 
starting agitation speed of 1000 rpm. Aeration was set at 3.5 L/min airflow to keep dissolved 
oxygen level higher than 30% (two bioreactors) and for one bioreactor the dissolved oxygen 
was kept at 5%. The second experiment was carried out at 28 °C, pH 5.0 (two bioreactors), pH 
6.0 (one bioreactor) and starting agitation speed of 1000 rpm (two bioreactors) and 1500 rpm 
(one bioreactor). Aeration was set at 3.5 L/min airflow to keep dissolved oxygen level higher 
than 5% (two bioreactors) and for one bioreactor the dissolved oxygen was kept at 30%. In the 
case where the airflow was limited, pure oxygen was provided. 25% ammonia solution was 
used to control pH and an antifoaming agent was added to prevent foaming. Both pH and 
dissolved oxygen parameters were monitored during cultivation with online probes.  
The glycerol batch phase lasted for ~24 hours until the entire carbon source was consumed 






3.3.2.3 Fed batch phase 
During this phase the culture was fed constantly with 14 mL/h/L (for 3.5 L of start volume: 49 
mL/h) 50% glycerol with PTM1 and biotin (both 12 mL/L fed-batch medium) for 17 hours. At 
defined time points during fed batch cultivations, sampling was performed to analyse dry cell 
weight (DCW) and OD600. 
The next morning, the glycerol-feed was turned off and after 30 minutes 100% methanol (17.5 
mL) was added to the bioreactor culture to a final methanol concentration of 0.5%. 
After glycerol consumption a constant methanol feed was set to 3 mL/h/L (for 3.5 L of start 
volume: 10.5 mL/h) pure methanol (without PTM1 or biotin). When methanol feed was added, 
the dissolved oxygen decreased and the rotation of the mixer was increased. The addaptation 
of cells to methanol, as their main carbon source, can be seen by restoring the dissolved oxygen 
to the set values. At defined time points during fed batch cultivations, sampling was performed 
to analyse dry cell weight (DCW). This flow rate was kept for 30 hours. At the end of the 
process, bioreactors were harvested.  
 Analyses 
3.3.3.1 OD600 
After each sampling, biomass changes were monitored by determining optical density (OD). 
Using a spectrophotometer, OD was measured at the wavelenght of 600 nm. Prior to 
measurements, the spectrophotometer had to be calibrated to a value of zero with distilled 
water. To obtain the correct results, the cell suspension in the 2 mL tube, had to be be stirred in 
order to obtain a homogeneous sample. As the spectrophotometer has a linear response in the 
range of 0.1 to 1, the sample was diluted with distilled water appropriately (i.e., 10 μL broth/990 
μL dH2O). 
3.3.3.2 Cell dry weight 
A sample of bioprocess broth (4 mL) was centrifuged in pre-weighed centrifuges (13,200 rpm, 
10 min, 4 °C) and than the supernatant was discarded. Pellets at the bottom of the tube were 
washed twice with 5 mL deionized water and re-centrifuged to get rid of salts and residual 






The bioreactor culture was harvested in 500 mL tubes by centrifugation at 1,000 g and 10 °C 
for 20 minutes. The pellet was washed once with 100 mM potassium phosphate buffer pH 7.4 
+ 8.5% sucrose, resuspended in potassium phosphate buffer (pH 7.0), transferred into fresh 50 
mL tubes and finally centrifuged again. The cell pellets were used directly for activity 
measurement (whole cell bioconversion; 50 mg wet pellet per mL potassium phosphate buffer 
(pH 7.0) without sucrose or stored at -80°C. 
3.3.3.4 Bioconversion 
Bioreactor content was pumped out of the vessel into 500 ml flasks and cells were harvested 
by centrifugation (5 min, 500 g), washed twice with 200 µL of assay buffer (100 mM potassium 
phosphate buffer, pH 7.4) and finally resuspended in 200 µL of assay buffer. 10 µL of obtained 
cell suspension was used for OD600 determination for later corrections. The cells were than 
frozen at -20°C for several days. The cells were thawed at room temperature and vortexed (30 
sec) for better mixing. To the cell suspension, 4 µL of a 100 mM substrate stock 
(testosterone/diclofenac) solution in MeOH was added. The whole-cell conversions were 
carried out for 16 h at 28 °C and 320 rpm. The next day, the reactions were stopped by the 
addition of 200 µL of MeOH and acetonitril (1:1), vortexed and centrifuged (10 min, 3200 g). 
200 µL of supernatants were transferred in fresh 96 well microtiter plates (polypropylene, V-
shaped), sealed and directly subjected to HPLC-MS analysis (text is summarized according to 





Preparation of 96 well microtiter plates for bioconversion: 
 
I. Ultra yield flask experiments: Cultivation of CYP3A4_A9, CYP2D6_D8, CYP2C9 
and BSYBG11  
 
Table 4 Cultivation of CYP3A4_A9, CYP2D6_D8, CYP2C9 and BSYBG11 in 96 deep well plate. Labels 1 – 8 means that 
experiment was carried out in 8 ultra yield flasks. Label 1.1 – 8.2 denotes that the experiment in 96 deep well plate was 
carried out in two paralels. Testosteron (Testo) and diclofenac (Diclo) were used as bioconversion substrates. 










flask 4.1 (3A4 + 









flask 2.3 (2C9 + 
CAA)  Diclo 
flask 3.2 
(3A4) Diclo 
flask 4.2 (3A4 + 






  7 8 9 10 11 12 
A 




flask 8.1 (BG11 
+ CAA) Diclo 
flask 7.1 
(BG11) Testo 
flask 8.1 (BG11 











flask 8.2 (BG11 
+ CAA) Diclo 
flask 7.2 
(BG11) Testo 
flask 8.2 (BG11 






II. Ultra yield flask experiments: Cultivation of CYP1A1, CYP2C9 and BSYBG11. 
 
Table 5 Cultivation of CYP1A1, CYP2C9 and BSYBG11 in 96 deep well plate. Diclofenac was used as a substrate for 
bioconversion. 




BUFFER + MeOH/AcN 
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III. Bioreactor experiment: Cultivation of CYP3A4_A9. 
Table 6 Cultivation of CYP3A4_A9 in 96 deep well plate. Testosteron was used as a substrate for bioconversion. 















H BUFFER + MeOH/AcN 
 
IV. Optimization of first bioreactor experiment: Cultivation of CYP3A4_A9. 
 
Table 7 Cultivation of CYP3A4_A9 in 96 deep well plate. Testosteron was used as a substrate for bioconversion. 
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Analyses were performed on a HPLC device equipped with a MSD SL detector (used to detect 
molecular weight, structure of molecules; it provides excellent selectivity required to identify 
compounds, to verify the purity of chromatographic peaks and to quantify trace samples) with 
an electron spray ionization (ESI) unit. For high-throughput screening purposes (analysis time 
6 min), the whole-cell reaction mixtures were separated on a Kinetex® 2.6 μm C18 100 Å, LC 
50 × 4.6 mm column (Phenomenex) at 25°C. The mobile phase was composed of acetonitrile 
(ACN) and water, acidified with 0.1% formic acid. Gradient-elution was performed at 1.0 
mL/min as follows: 
 
TIME PERCENT OF ACN 
0.00-1.00 min 20% 
1.01-3.00 min 20-100%  
3.01-5.00 min 100% 
5.01-6.00 min 20%  
 
The exact identification of metabolites and starting materials was established by comparing 
their retention times with those of authentic standards. The retention times for testosterone 






 RESULTS AND DISCUSSION 
This chapter summarises the results of the laboratory work provided as tables and graphs.  
Results are presented from cultivating P. pastoris in ultra yield flasks and in bioreactors. In 
both cases, open and closed systems for fungal culture cultivation were used. Yeast growth 
during the bioprocess was monitored through optical density measurement (OD600), using both 
online and periodic offline measurements. CYP450 activity with regards to model substrate 
conversion was determined by means of determining the concentration of respective oxidized 





 Cultivation of different strains of P. pastoris in UYF with and without 
addition of Casamino acids and measurement of testosterone  
& diclofenac bioconversion using HPLC 
Different strains of P. pastoris were were cultivated for 5 days under specified conditions, 
adding CA according to the protocol (Experimental scheme 1). After completion of the process, 
OD600 was measured in order to determine the effect of the CA on biomass (cell concentration). 
Results are presented in Figure 8. BSYBGII is the wild type yeast (Pichia pastoris without 
inserted CYP), which served as reference for comparison with others. The highest optical 
density was achieved when P. pastoris harboring CYP3A4 gene was cultivated, and the lowest 
in the reference strain BSYBGII. The cause for that might be because other strains (CYP3A4, 
CYP2D6, CYP2C9) have inserted PDC promoter, which is inducible with methanol and very 
strong. The purpose of the experiment was to demonstrate that adding CA affects (improves) 
cell growth in culture. Figure 8 shows that this was not the case, as growth with added CA was 
only slightly enhanced. For CYP3A4, optical density increased from 67.56 to 69.67. It can be 



































a) The results of testosterone bioconversion are presented in the Table 8 and Figure 9. 
Main goal of this experiment was determination of efficiency of testosterone bioconversion of 
Pichia pastoris with inserted different CYP450 enzymes. The experiment was performed in 
duplicates (to ensure better accuracy) and cultivated in ultra yield flasks in BMS medium. The 
results were obtained after performing HPLC analysis. 
Table 8 The results of whole cell testosterone bioconversion experiments, where the yeast were grown in Ultra yield flask in 
BMS 
STRAIN  
mean efficiency of testosterone bioconversion  
[% hydroxylated testosterone]  
STD 
CYP3A4_A9 (3.1) 19,26 0,11 
CYP3A4_A9 (3.2) 18,63 0,04 
CYP3A4_A9 (4.1 + CAA) 18,89 0,04 
CYP3A4_A9 (4.2 + CAA) 19,65 0,09 
CYP2D6_D8 (5.1) 7,74 0,04 
CYP2D6_D8 (5.2) 7,83 0,02 
CYP2D6_D8 (6.1 + CAA) 7,25 0,01 
CYP2D6_D8 (6.2 + CAA) 7,27 0,03 
BSYBG11 (7.1) 9,71 0,16 
BSYBG11 (7.2) 8,36 3,45 
BSYBG11 (8.1 + CAA) 9,90 0,12 
BSYBG11 (8.2 + CAA) 8,64 2,05 
 
The percent of bioconversion was calculated according to the Equations 2 and 3: 
Equation 2 (calculation of testosterone hydroxy conversion):  
𝐻𝑦𝑑𝑟𝑜𝑥𝑦 𝑐𝑜𝑛𝑣𝑒𝑟𝑠𝑖𝑜𝑛 =
ℎ𝑦𝑑𝑟𝑜𝑥𝑦 𝑡𝑜𝑡𝑎𝑙
𝑠𝑢𝑏𝑠𝑡𝑟𝑎𝑡𝑒 + ℎ𝑦𝑑𝑟𝑜𝑥𝑦 𝑡𝑜𝑡𝑎𝑙
100
 
Equation 3 (calculation of testosterone hydroxy total):  
𝐻𝑦𝑑𝑟𝑜𝑥𝑦 𝑡𝑜𝑡𝑎𝑙 = 𝑠𝑢𝑚(𝑝𝑟𝑜𝑑𝑢𝑐𝑡 1: 𝑝𝑟𝑜𝑑𝑢𝑐𝑡 4) 
 
It is supposed that the first step of the reaction was hydrolysis of ester bonds, followed by 
hydroxylation of the alcohol resulting from hydrolysis. It was assumed that adding CA would 
affect (improve) growth and consequently improve enzyme activity with regards to 
bioconversion of testosterone. It is known that casamino acids are a source of nitrogen and yeast 
grow better in richer media (higher biomass, shorter generation time). As mentioned above and 





The experiment was performed in duplicates. The highest activity was gained when P. pastoris 
expressing CYP3A4_A9 (19.65%) was cultivated, and after addition of CA (18.63%). The 
comparison between strains expressing CYP3A4 and CYP2D6 shows that enzyme activity 
judged from testosterone bioconversion is higher with CYP3A4.  
 
b) Testosterone bioconversion results per OD600 are presented in the Table 9 and Figure 
10. 
Main goal of this experiment was determination of cell density on the last day of the experiment 
and furthermore, assessment of percentage of testosterone bioconversion. Cell density was 





































Strains and cultivation conditions (MeOH concentration 1%, 28°C, 120 rpm)
W/O CA
WITH CA
 Figure 9: The results of testosterone bioconversion with whole cells grown in Ultra yield flasks with MeOH concentration 1%, 




Table 9 OD600 results and the results of testosterone percentage bioconversion per OD600 experiments, where the yeast were 
grown in Ultra yield flask in BMS medium. 
 STRAIN OD600 (cuvettes) 
% testosterone bioconversion 
per OD600 
STD 
CYP3A4_A9 (3.1) 67,6 0,285 0,002 
CYP3A4_A9 (3.2) 66,7 0,279 0,001 
CYP3A4_A9 (4.1 + CAA) 69,7 0,271 0,001 
CYP3A4_A9 (4.2 + CAA) 65,8 0,299 0,001 
CYP2D6_D8 (5.1) 61,2 0,127 0,001 
CYP2D6_D8 (5.2) 64,2 0,12 0,00 
CYP2D6_D8 (6.1 + CAA) 64,7 0,11 0,00 
CYP2D6_D8 (6.2 + CAA) 63,4 0,11 0,00 
BSYBG11 (7.1) 49,0 0,20 0,00 
BSYBG11 (7.2) 50,2 0,17 0,07 
BSYBG11 (8.1 + CAA) 49,4 0,20 0,00 
BSYBG11 (8.2 + CAA) 48,7 0,18 0,04 
 
The percent of hydroxylation per OD600 was calculated according to Equation 4: 
 
Equation 4 (calculation of % testosterone bioconversion per OD600) 
% 𝑏𝑖𝑜𝑐𝑜𝑛𝑣𝑒𝑟𝑠𝑖𝑜𝑛 𝑝𝑒𝑟 𝑂𝐷600 = 




































































Strains and cultivation conditions (MeOH concentration 1%, 28°C, 120 rpm)
W/O CA [OD600 (cuvettes)] WITH CA [OD600 (cuvettes)]
W/O CA [% bioconversion per OD600] WITH CA [% bioconversion per OD600]
 Figure 10: OD600 results and the results of testosterone percentage bioconversion per OD600 experiments in Ultra yield flasks 




OD600 of yeast cultures with and without CA was also compared. The graph shows that adding 
CA does not affect (CYP3A4_A9_2 and CYP2D6_D8_2) or only minimally affects cell 
concentration. This was measured on the last day of the process, and showed a range between 
60 and 70 for cells harbouring the two CYP genes, compared to between 48 and 51 for wild 
type cells.  
The above statement is supported by Figures 8 and 10, indicating that the percentage of 
bioconversion with and without CA is approximately identical for all strains. It ranges between 
0.11 % (CYP2D6) and 0.30 % (CYP3A4). 
 
c) Testosterone bioconversion results per CDW are presented in the Table 10 and  
Figure 11. 
Main goal of this experiment was determination of cell dry weight on the last day of the 
experiment and furthermore, identification of percentage of testosterone bioconversion. 
Samples were taken from bioreactors on the last day of experiment, centrifuged so that only 
cells (without supernatant) stayed in tubes and stored at 105 °C.  
Table 10 CDW (mg/ml) results and the results of testosterone percentage bioconversion per CDW experiments, where the 
yeast were grown in Ultra yield flask in BMS 
STRAIN  CDW (mg/ml) 
% testosterone 
bioconversion per mg 
CDW 
STD 
CYP3A4_A9 (3.1) 4,9 19,65 0,11 
CYP3A4_A9 (3.2) 4,6 20,25 0,04 
CYP3A4_A9 (4.1 + CAA) 5,9 16,01 0,03 
CYP3A4_A9 (4.2 + CAA) 5,2 18,89 0,09 
CYP2D6_D8 (5.1) 5,0 7,74 0,04 
CYP2D6_D8 (5.2) 5,3 7,39 0,02 
CYP2D6_D8 (6.1 + CAA) 4,4 8,24 0,01 
CYP2D6_D8 (6.2 + CAA) 4,1 8,87 0,04 
BSYBG11 (7.1) 4,2 11,56 0,19 
BSYBG11 (7.2) 4,4 9,50 3,92 
BSYBG11 (8.1 + CAA) 3,2 15,47 0,19 






The percent of bioconversion per mg CDW was calculated according to the equation 5. 
Equation 5 ( calculation of % testosterone bioconversion per mg CDW): 
% 𝑏𝑖𝑜𝑐𝑜𝑛𝑣𝑒𝑟𝑠𝑖𝑜𝑛 𝑝𝑒𝑟 𝑚𝑔 𝐶𝐷𝑊 = 





Figure 11 shows that adding CA has no effect on CDW, as dry weight is relatively comparable. 
The greatest amount of dry biomass was gained with CYP3A4_A9_1 (5.9 mg/mL), and the least 
with the wild-type strain (BSYBG11_1), i.e. 3.2 mg/mL.  
The duplicates are also relatively comparable, indicating that the experiment was conducted 
without errors. The share of dry biomass for CYP3A4_A9 strain culture with added CA 
increased in both cases, amounting to 5.9 mg/mL and 5.2 mg/mL for CYP3A4_A9_1 and 
CYP3A4_A9_2, respectively. The opposite is true for CYP2D6_D8. When adding CA, the share 
of biomass was 4.4 mg/mL (for duplicate 1) and 3.2 mg/mL (for duplicate 2), and was higher 
when CA was not added, i.e. 5 mg/mL and 5.3 mg/mL, respectively. Similar phenomenon was 
observed duplicates of the wild type strain BSYBG11.   
Contrasting results were obtained in testosterone bioconversion experiments, since the 
bioconversion percentage for CYP3A4_A9 without added CA was higher (19.65%) compared 


































































Strains and cultivation conditions (MeOH concentration 1%, 28°C, 120 rpm)
W/O CA WITH CA W/O CA WITH CA
 Figure 11: CDW results and the results of testosterone percentage bioconversion per CDW experiments in Ultra yield flasks 




The opposite is true for CYP2D6_D8 strain. When adding CA, the bioconversion percentage 
was 8.24% and 8.87% for duplicates 1 and 2, respectively, and was lower when CA was not 
added, i.e. 7.74% and 7.39%, respectively.  
 
d) The results of diclofenac bioconversion are presented in the Table 11 and Figure 12. 
Main goal of this experiment was determination of efficiency of diclofenac bioconversion of 
Pichia pastoris with inserted different CYP450 enzymes. The experiment was performed in 
duplicates (to ensure better accuracy) and cultivated in ultra yield flasks in BMS medium. The 
results were obtained after performing HPLC analysis. 
 
Table 11 The results of whole cell diclofenac bioconversion experiments, where the yeast were grown in Ultra yield flask in 
BMS 
 STRAIN 
mean efficiency of diclofenac 
bioconversion [% hydroxylated 
diclofenac] 
STD 
  W/O CA WITH CA W/O CA WITH CA 
CYP2C9_1 18,75 16,02 0,11 0,06 
CYP2C9_2 18,84 16,2 0,32 0,21 
BSYBGII_1 0,96 0,45 0,56 1,08 






The percent of bioconversion was calculated according to the equation 6: 
 
Equation 6 (calculation of diclofenac % bioconversion): 





The Figure 12 shows that there were no differences between duplicate cultivations. As 
mentioned above (for bioconversion of testosterone) and evident from the Fig. 12, adding CA 
do not affect activity. This is due to the reason that CA did not affect to cell growth and cells 



































Strains and cultivation conditions (MeOH concentration 1%, 28°C, 120 rpm)
W/O CA
WITH CA
 Figure 12: The results of diclofenac bioconversion with whole cells grown in Ultra yield flasks with MeOH concentration 




e) The results of diclofenac bioconversion per OD600 are presented in the Table 12 and 
Figure 13.  
Main goal of this experiment was determination of efficiency of diclofenac bioconversion of 
Pichia pastoris with inserted different CYP450 enzymes and furthermore determination 
identification of percentage of diclofenac bioconversion. The experiment was performed in 
duplicates, just to ensure better accuracy. The results were obtained after performing HPLC 
analysis.   
 
Table 12 OD600 results and the results of diclofenac percentage bioconversion per OD600 experiments, where the yeast were 
grown in Ultra yield flask in BMS 
 STRAIN OD600 (cuvettes) 
diclofenac bioconversion per OD600 
[% hydroxylated diclofenac]  
STD 
CYP2C9_1 54,6 0,340 0,06 
CYP2C9_2 52,7 0,358 0,05 
CYP2C9_1 + CA 55,8 0,358 0,06 
CYP2C9_2 + CA 56,1 0,289 0,15 
BSYBGII_1 49,0 0,020 0,09 
BSYBGII_2 47,1 0,024 0,04 
BSYBGII_1 + CA 49,4 0,009 0,12 
BSYBGII_2 + CA 50,1 0,005 0,07 
 
The percent of bioconversion per OD600 (normalization to OD600) was calculated according to 
equation 7. 
Equation 7 (calculation of % diclofenac bioconversion per OD600): 
% 𝑏𝑖𝑜𝑐𝑜𝑛𝑣𝑒𝑟𝑠𝑖𝑜𝑛 𝑝𝑒𝑟 𝑂𝐷600 = 






OD600 with and without added CA was also compared. The Figure 13 shows that adding CA 
does not affect or only minimally affects cell concentration. This was measured on the last 
day of the process, and showed a range between 49 and 55  for cells harboring the CYP2C9 
gene, compared to between 47 and 50  for wild type cells.  
The above statement is supported by Fig. 13, indicating that the percentage of bioconversion 
with and without CA is approximately identical for all strains and ranges between 0.01 % 

































































Strains and cultivation conditions (MeOH concentration 1%, 28°C, 120 rpm)
W/O CA [OD600 (cuvettes)] WITH CA [OD600 (cuvettes)]
W/O CA [% bioconversion per OD600] WITH CA [% bioconversion per OD600]
 Figure 13: OD600 results and the results of diclofenac percentage bioconversion per OD600 experiments in Ultra yield 




f)  Testosterone bioconversion results per CDW are presented in the Table 13 and Figure 
14. 
Main goal of this experiment was determination of diclofenac bioconversion efficiency of  
Pichia pastoris expressing different CYP450 enzymes and determination of cell dry weight on 
the last day of the experiment and furthermore, assessment of diclofenac bioconversion 
percentage per CDW. The experiment was performed in duplicates and cultivated in ultra yield 
flasks in BSM medium. The results were obtained after performing HPLC analysis.   
 
Table 13 The results of diclofenac percentage bioconversion & percent diclofenac bioconversion per CDW experiments, 
where the yeast were grown in Ultra yield flask in BMS 
  
STRAIN 









per mg CDW 
STD 
2C9 1.1 18,75 0,27 5,4 17,18 0,27 
2C9 1.2 16,02 0,25 5,2 18,12 0,25 
2C9 2.1  + CAA 16,02 0,24 5,2 15,22 0,24 
2C9 2.2  + CAA 16.20 0,26 5,1 15,89 0,26 
BSYBG11 1.1 0,96 0,95 4,2 1,15 0,95 
BSYBG11 1.2 1,12 0,70 4,6 1,22 0,7 
BSYBG11 2.1  + CAA 0,45 0,21 3,2 0,70 0,21 
BSYBG11 2.2  + CAA 0,25 0,50 3,5 0,36 0,5 
 
The percentage of bioconversion per OD600 was calculated according to equation 8: 
 
Equation 8 ( calculation of % diclofenac bioconversion per mg CDW): 
% 𝑏𝑖𝑜𝑐𝑜𝑛𝑣𝑒𝑟𝑠𝑖𝑜𝑛 𝑝𝑒𝑟 𝑚𝑔 𝐶𝐷𝑊 = 







Fig. 14 shows that adding CA has no effect on CDW, as dry weight is comparable for all strains. 
The greatest amount of dry biomass was gained from experiment with the CYP2C9 strain 
(duplicate 1; 5.4 mg/ml), and the least from experiment with the wild type strain (BSYBG11_1), 
i.e. 3.2 mg/ml.  
The duplicates are also relatively comparable. The share of dry biomass for CYP2C9 strain 
grown in medium containing CA increased marginally in both cases relatively to the wild type 
strain, amounting to 5.4 mg/mL for CYP2C9_1, and 5.1 for CYP2C9_2. Similar applies to the 
wild type strain BSYBGII. With addition of CA, the share of biomass was 4.2 mg/mL and 
4.6 mg/ml for duplicates 1 and 2, respectively, while in absence of CA, it was 3.2 mg/ml and 
3.5 mg/ml, respectively.  
Opposite results were obtained in bioconversion of testosterone, as the percentage of 
bioconversion for CYP2D6 strain grown in medium without CA was higher (17.18%) compared 
to CYP3A4_A9 strain grown under the same condition (15.22%). The same applies to the wild 
type strain. When CA was added to the growth medium, the bioconversion percentage was 
1.15% and 1.22% for duplicates 1 and 2, respectively, and was lower when CA was not added, 
i.e. 0.70% and 0.36%, respectively.  
In summary, we discovered that addition of Casamino acids does not have any impact on the 





































































Strains and cultivation conditions (MeOH concentration 1%, 28°C, 120 rpm)
W/O CA WITH CA W/O CA WITH CA
 Figure 14: CDW results and the results of diclofenac percentage bioconversion per OD600 experiments in Ultra yield flasks 




 Ultra yield flask experiment II: Cultivation of different P. pastoris strains 
and measurement of diclofenac bioconversion using HPLC 
Different strains of P. pastoris were cultivated for 5 days under specified conditions. Since the 
first experiment demonstrated that adding CA has no effect on growth, CA were omitted during 
the second experiment. After the process was completed, OD600 was measured, CDW 
determined, and enzyme activity assessed by performing whole cell diclofenac bioconversion.  
 

























on per mg 
CDW 
SD 
CYP1A1  40,35 16,68 50,20 0,804 0,332 7,1 28,42 11,74 
CYP2C9  68,64 5,84 57,65 1,191 0,101 8,0 42,90 3,65 
BSYBG11 9,65 1,69 49,87 0,194 0,034 6,7 7,20 1,26 
 
Our main goal of this experiment was determination of efficiency of diclofenac bioconversion 
of Pichia pastoris with inserted different CYP450 enzymes and determination of cell dry weight 
and optical cell density on the last day of the experiment and furthermore, identification of 
percentage of diclofenac bioconversion. The experiment was performed in duplicates, just to 
ensure maximum accuracy. The results were obtained after performing HPLC analysis. 
 
The comparison between whole cell bioconversion efficiency of diclofenac for the strains 
expressing CYP1A1 and CYP2C9 shows that enzyme activity is higher in CYP2C9 (68.64 %). 
For cells harboring the CYP genes, OD600 ranged between 50 and 58, and amounted to 49.87  
for the wild type strain. The share of dry biomass was approx. 7 mg/mL for all three processes.  
 
Table 14 The results of diclofenac percentage bioconversion & % diclofenac bioconversion per OD600 & percent diclofenac 




Fig. 16 shows the comparison in the percentage of whole cell diclofenac bioconversion 
normalized to OD600 and CDW. Based on the data obtained, the activity of CYP2C9 is higher, 
amounting to 42.90%. The percentage of bioconversion per OD600 is also the highest for this 
enzyme, amounting to 1.191.  
  
 Figure 16: Percent diclofenac bioconversion,/OD600/mg CDW/mg in Ultra yield flasks with MeOH concentration 1%, 28°C 
and 120 rpm. 




 Cell growth comparison of CYP2D6, CYP1A1 and BSYBGII in UYF 
The concentration of cells was monitored throughout the process (5 days). The first samples 
were collected 60 h after inoculation; the cells were in lag phase, or the phase of adjustment. 
After that, we waited for the cells to further multiply, and fresh medium was added (BMM10; 
buffered minimal methanol 5%). Fig. 17 shows that after addition of fresh medium, cells 
entered exponential phase (68 h after inoculation). During this phase, cells grow and divide. 
After the second induction (68 h after inoculation), we began with addition of methanol, and 
the cells slowly entered stationary phase. Cell cultures maintained stationary phase until the 
process ended (80 h). The process was terminated prior to death phase. 
A cell culture growth curve is the principal indicator of growth characteristics for each cell line 
and one of the most important parameters when comparing processes. It shows the change in 
cell count over time during the experiments. With this experiment, we wanted to compare the 
growth of different strains of P. pastoris. Fig. 18 shows that the growth is comparable. 
As a suppressing carbon source for the PAOX1 glycerol should be completely consumed before 
starting methanol feeding. Otherwise, certain amount of glycerol may suppress the AOX1 















CYP1A1_1 CYP1A1_2 CYP2C9_1 CYP2C9_2 BSYBG11_1 BSYBG11_2
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3 4 5 
 Figure 17: Comparison of cell growth of CYP2D6, CYP1A1 and BSYBGII in ultra yield flasks, after inoculation on a day 0 
and then twice per day till the end of the process. On Figure 17, only time points at which samples were taken are selected. 1. 
first induction with addition of 10 % BMM10; 2. second induction with addition of 1% methanol; 3. third induction with 




 Measurement of dry cell weight of CYP3A4 in bioreactor units under 
different conditions (testing different setting [pH, oxygen supply, T, 
stirring] in two separate bioreactor experiments) 
Main goal of the experiment was determination of dry cell weight of Pichia pastoris expressing 
different CYP450 enzymes after cultivation in bioreactors under different conditions.  
Experiment I was performed under the following conditions (CT stands for bioreactor unit): 
- CT1: dO2 5%, 500 rpm, pH 5.0 
- CT2: dO2 30%, 500 rpm, pH 6.0 

























Results of dry cell weight (mg/mL) of CYP3A4
CT1 (experiment_1) CT2 (experiment_1) CT+ (experiment_1)
CT1 (experiment_2) CT2 (experiment_2) CT+ (experiment_2)




Experiment II was performed under the following conditions: 
- CT1 and CT2: dO2 5%, 1000 rpm, pH 5.0 
- CT+: dO2 30%, 1500 rpm, pH 6.0 
 
Fig. 18 shows the dependence of viable cell mass on the duration of cultivation. Biomass was 
monitored throughout the process (5 days). Samples were collected from all three bioreactors 
(CT1, CT2 and CT+). The first samples were collected 16 h after inoculation; the cells were in 
lag phase, or the phase of adjustment. After that, we waited for the cells to further multiply, and 
fresh medium was added (glycerol; fed-batch process) before the medium was used up. After 
adding fresh medium, the cells entered exponential phase (24 h after inoculation). During this 
phase, cells grow and divide. The graph shows that exponential growth occurred between 24 h 
and 48 h after inoculation. After 48 h, glycerol was replaced by methanol, and the cells slowly 
entered stationary phase. Some deviation was observed for CT+, with the cells entering death 
phase 56 h after inoculation, as seen on the graph (grey). Another possibility is that an error 
was made during sampling (mixed-up samples). Deviation can also be observed for CT1 
(experiment 2; yellow). The cells entered stationary phase after 56 h, and remained at this 
growth phase until 72 h, after which their mass started to increase again, which almost certainly 
indicates a sampling error. Cell cultures maintained at the stationary phase until the process 
ended (96 h). The process was terminated prior to death phase. 
 
For the determination of growth kinetics, metabolic quotients (microbial respiration per unit of 
biomass) and yield factors, the biomass parameter is required. Above mentioned parameters are 
important for the analysis and improvement in microbial process efficiencies and for general 
physiological research. A disadvantage of this method is that we cannot readily distinguish 





 Cultivation of CYP3A4 in bioreactors under different conditions (pH, 
oxygen supply, T, stirring ) 
Main goal of this experiment was determination of efficiency of testosterone bioconversion of 
Pichia pastoris with inserted different CYP450 enzymes and determination of cell dry weight 
and optical density on the last day of the experiment and furthermore, identification of 
percentage of testosterone bioconversion. The results were obtained after performing HPLC 
analysis.  
a) The results of testosterone bioconversion, OD600 and CDW are presented in the table 
15 and Figure 19 (BR experiment I). 
Table 15 The results of testosterone percentage bioconversion & % testosterone bioconversion per OD600 & percent 













































Comparing CYP3A4 activity in cells, grown in three bioreactors under different conditions 
shows that judging from testosterone bioconversion, the highest enzyme acztivity was detected 
with cells from in experiment conducted in BR2.  
The reason is better yeast growth (higher biomass) - so there was more enzyme. If normalized 
to OD600 or to CDW, there is no difference. The activity of the enzyme is the same. The data 
obtained indicate that the optimum conditions for growth are pH 5.0, 1000 rpm and dO2 30%. 
In our experiments, cells were grown at two pHs (5.0 and 6.0). We found that cell growth at 
both pHs was comparable. The most suitable conditions for growth of P. pastoris are in the pH 
range between 3.0 - 7.0. Despite the relatively high range, this does not significantly affect on 
growth, allowing a lot of freedom in adjusting the pH to one that is not optimal for the 
problematic protease (36). pH between 5.0-6.0 and 3.0 is important during protein secretion 
into the medium and for optimal growh (37). 
Cultivation at lower temperatures may have an affect to the yield of recombinant proteins due 
to their poorer stability at higher temperatures (36). 
In our experiments, we compared two different concentrations of delivered dO2, 5% and 30%. 
We found that different concentrations had no effect on cell growth and enzyme activity. 
However, from the literature we found that oxygen supply is the main parameter in the 
cultivation of P. pastoris due to its high demand in methanol metabolism (38).  
The growth of P. pastoris on methanol requires the maintenance of dissolved oxygen at a 








BR1 (pH 5.0, dO2
5%, 1000 rpm)
BR2 (pH 5.0, dO2
30%, 1000 rpm)







































Bioreactor unit and cultivation conditions
testosterone % hydroxy
bioconversion mean
% bioconversion per OD600
% bioconversion per mg CDW




Cultivation of a higher concentration of cells on methanol requires the need for additional 
oxygen, in order to maintain a constant concentration of dissolved oxygen in the bioreactor 
(38). During cell growth, oxygen is consumed and the dO concentration is kept low (37). 
The oxygen concentration in the medium can be increased with stirring (500 to 1500 rpm) (39).  





b) The results of testosterone bioconversion per CDW and OD600 are presented in the 
Figure 20 and Table 15 under point a (BR experiment I). 
Goal of this experiment was determination of efficiency of testosterone bioconversion of Pichia 
pastoris with inserted different CYP450 enzymes and determination of cell dry weight and 
optical density on the last day of the experiment and furthermore, identification of percentage 
of testosterone bioconversion. The results were obtained after performing HPLC analysis. 
 
The percentage of bioconversion normalized to CDW in BR1 and BR2 amounts to approx. 
33%, even though the bioreactor experiments were conducted under different conditions. 
Specifically, pH and mixing speed were identical in both experiments, the difference was in 
oxygen supply. Fig. 20 shows that it can be concluded that oxygen has no significant impact on 
cell growth and consequently on recombinant CYP production. Comparing BR3 and BR2 
experiments (where the highest CDW was attained), the only difference is pH. This means that 
pH has a significant impact on cell growth and that lower pH is better for fungal cell growth. 
The percentage of bioconversion per OD600 shows similar results as described above. Optimal 
growth conditions were in bioreactors 1 and 2, and again proved that dO2 has no effect on cell 
growth. Again, comparing BR3 and BR1 (highest OD600) shows that the only difference is pH. 
The percentage of bioconversion increases with decreasing pH, indicating that lower pH is 




















BR1 (pH 5.0, dO2 5%, 1000
rpm)
BR2 (pH 5.0, dO2 30%,
1000 rpm)















































Bioreactor unit and cultivation conditions
% bioconversion per mg CDW % bioconversion per OD600




c) The results of testosterone bioconversion , OD600 and CDW are presented in the Table 
16 and Figure 21 and 22 (BR experiment II). 
Goal of this experiment was determination of efficiency of testosterone bioconversion of Pichia 
pastoris with inserted different CYP450 enzymes and determination of cell dry weight and 
optical density on the last day of the experiment and furthermore, identification of percentage 
of testosterone bioconversion. The results were obtained after performing HPLC analysis.   
 
Table 16 The results of testosterone percentage bioconversion & percentage testosterone bioconversion per OD600 & 









































The first bioreactor experiment showed that the highest enzyme activity is gained in cells 
growing at pH 5.0, mixing at 1000 rpm and 30% dO2, and at pH 5.0, mixing at 1000 rpm and 
5% dO2. 
Fig. 21 shows that with comparing CYP3A4 in three bioreactors under different conditions, 
enzyme activity judging from testosterone bioconversion is the highest in reactor 2. For cells 
with inserted CYP, OD600 ranged between 61 and 89 x 10
7 cells/ml. The share of dry biomass 
was approx. 6 mg/ml for all three processes. The data obtained indicate that the optimum 



































































Fig. 22 shows that the percentage of bioconversion per CDW in BR2 and BR3 amounted to 
approx. 21%, even though the bioreactor experiments were conducted under different 
conditions. The same conditions were used for BR1 and BR2, but there is difference in 
bioconversion per OD600 (fig. 22). It can be concluded that dO2 concentration has no significant 
effect on cell growth, and consequently on the percentage of bioconversion per CDW. 
Comparing BR3 and BR2 (highest CDW), the only difference is pH. This means that pH has a 
significant effect on cell growth and that lower pH is better for fungal cell growth. 
The percentage of bioconversion per OD600 shows similar results as described above. Optimal 
growth conditions were in bioreactors 1 and 2, and again proved that dO2 has no effect on cell 
growth. Again, comparing BR3 and BR1 (highest OD600) shows that the only difference is pH. 

















BR1 (d02 5%, 1000rpm, pH
5.0)
BR2 (d02 5%, 1000rpm, pH
5.0)



















































Bioreactor unit and cultivation conditions
% bioconversion per mg CDW % bioconversion per OD600




 Comparison of enzyme activity between bioreactor and ultra yield flasks experiments 
Main goal of this experiment was comparison of whole cell diclofenac bioconversion between yeast expressing different CYP450 enzymes 
cultivated in bioreactors and ultra yield flasks. The results were obtained after performing HPLC analysis. 
Fig. 23 compares enzyme activity in cells cultivated in bioreactors and UYF. The highest enzyme activity was recorded for bioreactor cultivation, 









































































bioreactor unit vs UYF under different cultivation conditions




Enzyme activity was up to 4-times lower for UFY cultivation compared to BR. This is because 
the conditions in BR units are controlled, and can be modified and adjusted according to the 
needs of the cultured organism, which is not possible in UYF.   
 
Cultivation of microorganisms in Ultra yield flask is a simple method of fermentation. 
Important nutrients, like carbon, are provided to microorganisms throught medium. Shaking of 
flasks during cultivation is important, because mixing increases homogeneity and provides 
better aeration. They represent a low-cost alternative to expensive larger-scale bioreactor 
systems and are a lot easier to handle (32). The disadvantage is that there is no real-time control 
over important parameters of the culture. The production of large amounts of protein is 
hampered by limited volume, difficult oxygen supply and restrictions on the addition of 
substrates (31). 
 
Disadvantage of fed batch experiments is that there is a significant increase in unusable by-
products during the process. In some cases, these can have a toxic effect on our cells. The 
advantage of this process, however, is that a higher concentration of cells and consequently a 
higher concentration of the product can be achieved (34). The addition of glycerol affects the 








In this research we optimized the expression of several human CYP450 paralogs in the 
methylotrophic yeast Pichia pastoris. The aim was to change the degree of aeration, pH of the 
medium and mixing speed during the cultivation of yeasts. The catalytic activity of CYP450 
was evaluated by incubation of the model active ingredients testosterone and diclofenac in 
suspensions of recombinant yeast cells, extraction of metabolites and their analysis by HPLC. 
Below we list the most important findings: 
 
- The highest optical cell density was measured in yeasts expressing CYP450 3A4 
and the lowest in the BSYBGII strain (P. pastoris without the inserted CYP gene). 
This was unexpected, as yeasts (wild-type strain) do not need to invest energy 
in the biosynthesis of recombinant protein, so they only invest energy in 
reproduction. 
 
- The comparison of CYP1A1- and CYP2C9-expressing strains shows that 
enzyme activity judging from diclofenac bioconversion is higher in CYP2C9. 
This was expected as CYP450 CYP2C9 is selective for diclofenac (there is no 
testosterone hydroxylation). 
 
- The most suitable pH conditions for growth of P. pastoris in bioreactors are in 
the range between 3.0 - 7.0. 
 
- In bioreactor experiments, we compared two different concentrations of 
delivered dO2, 5% and 30%. We found that different concentrations had no 
effect on cell growth and enzyme activity. The data obtained indicate that the 
optimum conditions for growth are pH 5.0, 1000 rpm and dO2 30%. 
 
- Enzyme activity was up to 4-times lower for UFY cultivation compared to BR. 
This is because the conditions in BR units are controlled, and can be modified 
and adjusted according to the needs of the cultured organism, which is not 
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